Abstract:Homologous recombination (HR) is an important mechanism for repairing DNA double-strand breaks (DSBs) and preserving genome integrity. Pathogenic mutations in the HR proteins BRCA2 and the RAD51 paralogs predispose individuals to breast, ovarian, pancreatic, and prostate cancer. The RAD51 paralogs: RAD51B, RAD51C, RAD51D, XRCC2, and XRCC3 form two complexes RAD51B-RAD51C-RAD51D-XRCC2 (BCDX2) and RAD51C-XRCC3 (CX3). Similar to BRCA2, loss of RAD51 paralog functions in mammalian cells lead to chromosomal abnormalities, growth defects, disrupted RAD51 foci formation, and PARP inhibitor sensitivity. Despite significant effort over the past three decades, the specific molecular functions of the human RAD51 paralogs have remained elusive due to technical challenges such as low protein expression in human cell lines and instability of the purified proteins. Recent studies have determined the molecular structures of the BCDX2 and CX3 complexes dramatically enhancing our understanding of these challenging proteins. Using multiple approaches, we demonstrate that the RAD51 paralogs interact with BRCA2 at two distinct interaction hubs located in the BRC repeats and the DNA binding domain. We confirm, using a yeast 3-hybrid approach, that human RAD51 paralogs interact directly with BRC repeats one and two (BRC1-2) of BRCA2. Because of the dynamic nature of the RAD51B C-terminal domain (CTD), identified in the recently solved cryo-EM structures, we focused on elucidating the interaction with RAD51B. We determined that BRCA2 interacts with the CTD of RAD51B and not the N-terminal domain (NTD) that is involved in stacking interactions with RAD51C and RAD51D. Furthermore, the interaction with RAD51B is dependent upon an FxxA motif located on a surface exposed region of the CTD. Our study has identified novel interactions between the RAD51 paralogs and BRCA2 and further demonstrated that a previously unrecognized FxxA motif located within a mobile element of RAD51B is critical for the interaction.

Distinct binding of BRCA2 BRC repeats to RAD51 generates differential DNA damage sensitivity

Abstract 5603: Defining the functions of the BRCA2 BRC repeats in modulating RAD51 binding and activity

BRCA1–BARD1 Promotes RAD51-mediated Homologous DNA Pairing

DMC1 and RAD51 bind FxxA and FxPP motifs of BRCA2 via two separate interfaces

A Variant of the Breast Cancer Type 2 Susceptibility Protein (BRC) Repeat is Essential for the RECQL5 Helicase to Interact with RAD51 Recombinase for Genome Stabilization

Distinct roles of the two BRCA2 DNA binding domains in DNA damage repair and replication fork preservation

BRCA2 C-terminal clamp restructures RAD51 dimers to bind B-DNA for replication fork stability

The Epistatic Relationship Between BRCA2 and the Other RAD51 Mediators in Homologous Recombination

BRCA2 stabilises RAD51 and DMC1 nucleoprotein filaments through a conserved interaction mode

RAD51 Paralogs and RAD51 Paralog Complexes BCDX2 and CX3 Interact with BRCA2

RAP80-directed Tuning of BRCA1 Homologous Recombination Function at Ionizing Radiation-Induced Nuclear Foci.

Improved RAD51 binders through motif shuffling based on the modularity of BRC repeats

BRCA1 Interaction with Non-Canonical DNA Structures: Insights into Genome Maintenance and Disease Mechanisms

Visualization of direct and diffusion-assisted RAD51 nucleation by full-length human BRCA2 protein.

Expression of BRC Repeats in Breast Cancer Cells Disrupts the BRCA2-Rad51 Complex and Leads to Radiation Hypersensitivity and Loss of G(2)/M Checkpoint Control.

BRCA2 regulates DMC1-mediated recombination through the BRC repeats

Involvement of BRCA2 Repeats in RAD51 Mediated DNA Repair

Molecular Functions of BRCA1 in the DNA Damage Response

A phosphorylation-deubiquitination cascade regulates the BRCA2-RAD51 axis in homologous recombination.

A Second DNA Binding Site in Human BRCA2 Promotes Homologous Recombination

BRCA1 and CtIP suppress long-tract gene conversion between sister chromatids